Research Analysts Issue Forecasts for Orthofix International N.V.’s Q1 2018 Earnings (OFIX)
Orthofix International N.V. (NASDAQ:OFIX) – Analysts at SunTrust Banks issued their Q1 2018 earnings per share (EPS) estimates for shares of Orthofix International N.V. in a research note issued to investors on Tuesday. SunTrust Banks analyst B. Nudell anticipates that the medical device company will post earnings of $0.34 per share for the quarter. SunTrust Banks has a “Buy” rating and a $49.00 price target on the stock. SunTrust Banks also issued estimates for Orthofix International N.V.’s Q2 2018 earnings at $0.53 EPS, Q4 2018 earnings at $0.62 EPS, FY2019 earnings at $2.24 EPS, FY2020 earnings at $2.56 EPS and FY2021 earnings at $2.72 EPS.
Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The firm had revenue of $108.90 million during the quarter, compared to the consensus estimate of $102.94 million. During the same period last year, the firm earned $0.41 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. COPYRIGHT VIOLATION WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/research-analysts-issue-forecasts-for-orthofix-international-n-v-s-q1-2018-earnings-ofix/1472979.html.
A number of other brokerages have also weighed in on OFIX. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Thursday. Jefferies Group LLC reaffirmed a “buy” rating and set a $55.00 price target (up previously from $50.00) on shares of Orthofix International N.V. in a research note on Thursday. TheStreet raised shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research note on Tuesday. BidaskClub downgraded shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Finally, BTIG Research began coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 21st. They set a “buy” rating and a $52.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $52.75.
Orthofix International N.V. (NASDAQ OFIX) traded up 0.25% during mid-day trading on Friday, hitting $47.36. 26,626 shares of the stock traded hands. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $49.60. The company has a market cap of $860.53 million, a P/E ratio of 110.91 and a beta of 0.25. The company’s 50 day moving average is $45.63 and its 200 day moving average is $40.81.
A number of hedge funds and other institutional investors have recently bought and sold shares of OFIX. State Street Corp increased its position in Orthofix International N.V. by 5.6% in the fourth quarter. State Street Corp now owns 364,267 shares of the medical device company’s stock valued at $13,179,000 after buying an additional 19,395 shares in the last quarter. Norges Bank acquired a new position in shares of Orthofix International N.V. during the fourth quarter valued at about $5,664,000. Teachers Advisors LLC boosted its position in shares of Orthofix International N.V. by 18.2% in the fourth quarter. Teachers Advisors LLC now owns 35,600 shares of the medical device company’s stock valued at $1,288,000 after buying an additional 5,489 shares during the last quarter. Capstone Asset Management Co. acquired a new position in shares of Orthofix International N.V. during the first quarter valued at about $204,000. Finally, Louisiana State Employees Retirement System acquired a new position in shares of Orthofix International N.V. during the first quarter valued at about $278,000. 99.68% of the stock is currently owned by institutional investors.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.